{
 "drug": "Disopyramide Phosphate Capsule, Extended Release",
 "asOf": "2026-10-09",
 "status": "discontinuing",
 "since": "08/24/2026",
 "dayN": 46,
 "cat": "Cardiovascular",
 "companies": [
  "Pfizer Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "08/24/2026",
   "update_type": "New",
   "initial_posting_date": "08/24/2026",
   "package_ndc": "0025-2732-31",
   "generic_name": "Disopyramide Phosphate Capsule, Extended Release",
   "contact_info": "800-533-4535",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/24/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "08/24/2026",
   "update_type": "New",
   "initial_posting_date": "08/24/2026",
   "package_ndc": "0025-2742-31",
   "generic_name": "Disopyramide Phosphate Capsule, Extended Release",
   "contact_info": "800-533-4535",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/24/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Capsule, Extended Release",
   "presentation": "Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  }
 ],
 "firstSeen": "2026-08-26",
 "history": [
  {
   "date": "2026-08-26",
   "kind": "new",
   "to": "discontinuing",
   "text": "Disopyramide Phosphate Capsule, Extended Release appeared on the FDA shortage list (being discontinued)"
  }
 ]
}